MedicarePartD.guide

A non-government resource built from CMS public data

XULTOPHY 100/3.6 100/3.6 [iU]/mL/mg/mL Injection, Solution

Also known as Insulin Degludec And Liraglutide. Coverage in Wisconsin (CMS PDP Region 16).

1 of 10 stand-alone Part D plans in Wisconsin cover this drug on tier 3.

1 of 1 plans apply a prior authorization, step therapy or quantity limit.

19 Medicare Advantage plans in WI do cover it

Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. WI: 19 plans.

Every plan that covers it

PlanTier30-day preferred90-day mailUnit costEst. 30-day fillRestrictions
SilverScript Choice (PDP)$26.70/mo premium · $615.00 deductible3Preferred Brand19%19%$88.0424$1,320.6415 units
  • Quantity limit 15 per 30 days

Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.

See coverage in all 39 regions →